Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Immunology  |  Oncology

Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1413) clinical trials

People with Lymphoma and Leukemia are asked to participate in a research study being conducted by Long Island Jewish Medical Center.

Phase N/A

People with chronic lymphocytic leukemia are asked to participate in a research study being conducted by White Plains Hospital.

Phase N/A

People with Lymphoma and Leukemia are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

People with T- and NK-cell Neoplasms are asked to participate in a research study being conducted by North Shore University Hospital.

Phase N/A

The purpose of this study is to evaluate the safety and efficacy of two INCB050465 treatment regimens in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.

Phase

People with chronic lymphocytic leukemia are asked to participate in a research study being conducted by Northwell Health.

Phase N/A

A research study is evaluating the effects of an investigational topical medication combined with light therapy for the potential treatment of Cutaneous T-Cell Lymphoma.

Phase

89Zr-Df-IAB22M2C PET/CT in Patients With Selected Metastatic Solid Malignancies or Hodgkin's Lymphoma

This is a phase I study of positron emission tomography (PET/CT) with 89Zr-Df-IAB22M2C in patients with selected solid malignancies (NSCLC, SCLC, SqCCHN, melanoma, merkel cell tumor, renal, bladder, hepatocellular, triple negative breast, or gastroesophageal cancer) or Hodgkin's lymphoma. Up to 24 subjects are planned to be enrolled in this clinical ...

Phase

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

PRIMARY OBJECTIVES: I. To assess the clinical benefit of nivolumab in T-cell lymphomas, as measured by objective response rate (ORR) within 12 cycles according to the Lugano Classification Response Criteria (2014). SECONDARY OBJECTIVES: I. To assess safety and tolerability of the regimen in this patient population. II. To assess progression-free ...

Phase

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy

The incidence of DLBCL is increasing and with an expanding elderly population, the incidence will continue to rise. Given that about 40% of cases of DLBCL occur in patients aged over 70 and the number of co-mobilities increases with age, research to investigate the optimal treatment of DLBCL in this ...

Phase